Emergence of a novel b-lactamase in food of animal origin: characterization of SHV-111, from a cheese isolate of Klebsiella pneumoniae, with an amino acid substitution in a strictly conserved position (P174S) in the -loop
The -loop is a conserved structural element in all class A b-lactamases. Amino acid substitutions in this loop appear to change the conformational flexibility of the catalytic region, resulting in the evolution of b-lactamases. The stepwise accumulation of mutations observed during the emergence of extended-spectrum b-lactamases (ESBLs) makes it highly probable that higher-order combinations of mutations occurred in clinical settings potentially after exposure to antibiotics [1] . One mutation may change the active site topology, another may enhance catalytic activity and some may be compensatory. The current hypotheses for the evolution of b-lactamases are drawn mainly from human clinical studies and in vitro evolution experiments. However, as stated by Martínez et al. [2] 'an accurate prediction of evolutionary trajectories, all the steps in evolution that are required to produce a given phenotype, requires better measurements and a more complete understanding of all selection pressures in both human and animals, environmental variations and evolutionary constraints that constitute the real determinants for the correct natural evolutionary pathways'. Therefore, understanding the effect of novel amino acid substitutions on the phenotypic characteristics of SHV b-lactamases that keep the catalytic site accessible for even traditional b-lactam antibiotics is of utmost importance. In light of the scarcity of data on the role of non-clinical isolates in the evolution of b-lactamases, we characterized a novel SHV b-lactamase, SHV-111, from a cheese isolate (KP-DC6-2), which was identified during monitoring of traditional Egyptian Domiati cheese for ESBLs using conserved primers [3] . The bla SHV-111 gene was amplified by PCR using the primer pair SHV-F2 (CGGCC TTCACTCAAGGATGTA) and SHV-R2 (GTGCTGC-GGGCCGGATAAC). The purified whole PCR fragment of the bla SHV-111 gene containing only the coding region was cloned into the SmaI-digested plasmid vector pBAD33 using the TaKaRa Ligation kit (Takara Bio). This cloning vector has a chloramphenicol resistance gene and the P BAD promoter of the araBAD (arabinose) operon for gene expression. The new recombinant plasmid was named pSHV-111 and used to transform Escherichia coli TG1 for expression of the cloned bla SHV-111 . E. coli TG1 expressing the bla SHV-111 gene (TG1/pSHV-111) was phenotypically characterized by the broth microdilution method. The results were interpreted according to CLSI [4] guidelines for an ESBL producer: an MIC value of at least one extendedspectrum cephalosporin (ceftazidime and ceftriaxone) or aztreonam of !2 mg l
À1
. Analytical IEF was conducted to detect the isoelectric point (pI) and Southern blot analysis was carried out for localization of this gene. Sequence analysis of the bla SHV-111 gene (GenBank accession number, AB372881) revealed five silent nucleotide substitutions (in comparison with bla SHV-1 , GenBank accession number, AF148850) of CfiT, AfiG, GfiA, CfiG and CfiG at positions 357, 402, 705, 759 and 786, respectively. Interestingly, a codon change of CCC to TCC resulted in one amino acid substitution, serine instead of proline at the strictly conserved Ambler position 174, namely, P174S. This amino acid substitution was not enough to widen its substrate profile (Table 1) to meet the criteria of CLSI [4] for ESBL producers. Analysis of the b-lactamase content by IEF showed the presence of a single b-lactamase co-focusing with SHV-1 (pI 7.6). Southern hybridization analysis revealed chromosomal localization of this gene (data not shown).
Interestingly, substitution of the proline at position 174 has never been detected in previously identified SHV b-lactamases (http://www.lahey.org/studies/). A previous study [5] found that residue P174 displays the largest structural deviation (>0.45 nm) in the -loop that allows the entrance of blactam antibiotics to the active site of TEM b-lactamases. Another interesting study [6] conducted mutant selection with chromosomally encoded PenA from Burkholderia thailandensis and found that amino acid substitution of serine instead of proline at position 174 resulted in a limited expansion in substrate spectrum of the produced enzyme in comparison with some other substitutions. Similarly, in our case, SHV-111 did not show elevated ceftazidime and other oxyimino-cephalosporin MICs and maintained the basal function of SHV b-lactamases as it conferred resistance to ampicillin (Table 1 ). In the same context, Winkler et al. [7] observed that not all substitutions in the -loop resulted in significant expansions of the substrate spectrum of SHV blactamases as the strains carrying 167 variants did not show elevated MIC for ceftazidime (0.5 mg l
).
The residue P174 is conserved in multiple class A enzymes. Therefore, it seems likely that this position was fixed early in the evolution of the family of enzymes. Further studies are still needed to assess the effect of such amino acid substitutions and the combination of substitutions on the topology and catalytic activity of the active site of SHV blactamases. The reason why some variants of the b-lactamase genes are mainly found in human isolates and not in food or animal isolates could be attributed to the use of different b-lactams in humans and animals or, probably, to a lack of studies with animal and food isolates. Our study describes the first serious attempt to characterize a structural novel SHV b-lactamase with a mutation in a highly conserved Ambler position from a non-clinical isolate of Klebsiella pneumoniae. Also, it provides evidence that the evolution of b-lactamases in K. pneumoniae emerged from food of animal origin, and may develop novel combinations of mutations when exposed to antibiotics in clinical settings, enabling them to unexpectedly hydrolyse the most potent antibiotics in clinic. The likelihood of this as a clinical risk remains to be ascertained.
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